Hanau, Hessen, Germany Heraeus is the famous Corporate Investor, which was founded in 1851. The main department of described Corporate Investor is located in the Hanau. The venture was found in Europe in Germany.
The important activity for fund was in 2015. The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Forciot, Locate Bio, Ankasa Regenerative Therapeutics. Among the most popular fund investment industries, there are Health Care, Therapeutics.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Heraeus, startups are often financed by Volvo Cars Tech Fund. The meaningful sponsors for the fund in investment in the same round are Volvo Cars Group, Correlation Ventures, Avalon Ventures. In the next rounds fund is usually obtained by Midlands Engine Investment Fund, Mercia Technologies, Innovate UK.
Related Funds
| Fund Name | Location |
| Big Bloom Investment | China, Hong Kong, Hong Kong Island |
| EIG Global Energy Partners(EIG) | District of Columbia, United States, Washington |
| Energy Ventures | Canada, Ontario, Ottawa |
| Epsilon Venture Partners | China, Hong Kong, Hong Kong Island |
| Ezentis | Community of Madrid, Madrid, Spain |
| GT Fund | China, Hangzhou, Zhejiang |
| Guangzhou Shi Bingdu Touzi Hehuo Qiye (Limited Partnership) | China, Guangdong, Guangzhou |
| Keyframe Capital Partners | New York, New York, United States |
| March Holding | Dubai, United Arab Emirates |
| Masdar Capital | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
| Risk Consulting Partners | Missouri, St Louis, United States |
| RocaSalvatella | Barcelona, Catalonia, Spain |
| SATUS Starter | Kraków, Malopolskie, Poland |
| Scottish EDGE | Glasgow, Glasgow City, United Kingdom |
| Sichuan Culture Industry Fund | China, Gansu, Sichuan |
| Sunflower Investment | China, Futian, Guangdong |
| The Austrian Research Promotion Agency (FFG) | Austria, Vienna |
| The Pacific Securities | China, Yunnan, Yünnan |
| UNCDF | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tsubame BHB | $48M | 20 Feb 2024 | Chiyoda, Japan | ||
MimiX Biotherapeutics | 21 Dec 2022 | Neuchâtel, Switzerland | |||
Forciot | $4M | 30 Jan 2019 | Tampere, Finland | ||
Forciot | $4M | 29 Jan 2019 | Tampere, Finland | ||
Ankasa Regenerative Therapeutics | $8M | 23 Jun 2015 | San Diego, California, United States | ||
Locate Bio | 09 Jun 2014 | Nottingham, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tsubame BHB | $48M | 20 Feb 2024 | Chiyoda, Japan | ||
MimiX Biotherapeutics | 21 Dec 2022 | Neuchâtel, Switzerland | |||
Forciot | $4M | 30 Jan 2019 | Tampere, Finland | ||
Forciot | $4M | 29 Jan 2019 | Tampere, Finland | ||
Ankasa Regenerative Therapeutics | $8M | 23 Jun 2015 | San Diego, California, United States | ||
Locate Bio | 09 Jun 2014 | Nottingham, England, United Kingdom |
